Neoadjuvant therapy for patients with high risk stage III melanoma
|Effective start/end date||6/1/18 → 11/30/24|
- MAYO CLINIC ROCHESTER
- AMERICAN ASSOCIATION FOR CANCER RESEARCH
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.